| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Finance &Accounting
1 company
Thomson Peter G. is a VP Finance &Accounting at Fulcrum Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $9K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Buy | 2,300 | $9.00 | $20,700.00 | New | +202.6% | -46.2% | |
| Feb 22, 2021 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Sale+OE | 5,000 | $14.72 | $73,581.50 | -24.7% | - | - | |
| Jan 21, 2021 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Sell | 6,607 | $14.00 | $92,498.00 | -30.3% | - | - | |
| May 11, 2020 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Sell | 7,500 | $16.00 | $120,000.00 | -26.3% | - | - | |
| Feb 24, 2020 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Sell | 5,000 | $16.83 | $84,152.88 | -5.4% | - | - | |
| Jan 23, 2020 | FULC Fulcrum Therapeutics, Inc. | VP Finance &Accounting | Sell | 5,000 | $17.22 | $86,101.96 | -6.9% | - | - |